Skip to main content
Hugel, Inc. logo

Hugel, Inc. — Investor Relations & Filings

Ticker · 145020 ISIN · KR7145020004 KO Manufacturing
Open in API
Filings indexed 499 across all filing types
Latest filing 2025-02-07 Regulatory Filings
Country KR South Korea
Listing KO 145020

About Hugel, Inc.

https://www.hugel-inc.com/

Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.

Recent filings

Filing Released Lang Actions
풍문또는보도에대한해명 (미확정)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a 'Clarification of Rumors or Reports' (풍문 또는 보도에 대한 해명). It addresses a specific media report (Bloomberg) concerning potential delisting or strategic changes by the company's major shareholder. As this is a standard regulatory disclosure requirement for listed companies in Korea to address market rumors and does not fit into specific categories like M&A or Delisting (as it explicitly states the matter is 'undetermined'), it is classified as a general Regulatory Filing (RNS).
2025-02-07 Korean
결산실적공시예고
Report Publication Announcement Classification · 100% confidence The document is a short notice titled '결산실적공시 예고' (Notice of Earnings Release Schedule). It informs shareholders of the upcoming date (2025-02-13) for the release of the 2024 annual financial results. Since it is an announcement regarding the timing of a future report rather than the report itself, it falls under the Report Publication Announcement (RPA) category.
2025-02-06 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) notifying the public of an upcoming investor relations (IR) conference call to discuss 2024 Q4 and annual financial results. It provides the date, time, and location of the event, and mentions where the materials will be posted. Per the 'Menu vs Meal' rule, this is an announcement of an event/report rather than the report itself, and it fits the definition of a Regulatory Filing (RNS) as it is a standard corporate disclosure of an IR event.
2025-02-06 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event, specifically the company's participation in the JP Morgan Healthcare Conference and subsequent Non-Deal Roadshows (NDR). It provides details such as dates, locations, target audience, and the purpose of the meetings. Since this is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory notification of an IR activity, it is classified as a Regulatory Filing (RNS).
2025-01-09 Korean
투자판단관련주요경영사항 (미국 국제무역위원회(ITC, International Trade Commission) 최종심결에 대한 상대방 항소에 이해관계자로 참가 결정)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Hugel regarding their participation as an interested party in an appeal at the U.S. Court of Appeals for the Federal Circuit (CAFC) following an ITC ruling. This is a disclosure of a legal proceeding/litigation update. Since it specifically details a legal matter and does not fit into other categories like M&A or financial reports, it is classified as a Legal Proceedings Report.
2025-01-07 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to attend the 24th Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of a corporate action (setting a record date). Given its nature as a regulatory notification regarding shareholder rights and meeting preparation, it fits best under the general regulatory filing category.
2024-12-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.